Tumor ablation plus interferon therapy can reduce the risk of death for patients with hepatitis B virus or hepatitis C virus-related resectable hepatocellular carcinoma - A meta-analysis of randomized controlled trials -

被引：0
|
作者：
Moriguchi, Hisashi
Uemura, Takamoto
Sato, Chifumi
Chung, Raymond T.
机构：
[1] Univ Tokyo, Lab Syst Biol & Med, Tokyo 106, Japan
[2] Kyorin Univ, Sch Med, Mitaka, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Analyt Hlth Sci, Tokyo 113, Japan
[4] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Boston, MA 02115 USA
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1135
引用
收藏
页码：611A / 611A
页数：1
相关论文
共 50 条
  • [41] Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
    Miyake, Y.
    Takaki, A.
    Iwasaki, Y.
    Yamamoto, K.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (04) : 287 - 292
  • [42] Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus
    Shiratori, Y
    Shiina, S
    Teratani, T
    Imamura, M
    Obi, S
    Sato, S
    Koike, Y
    Yoshida, H
    Omata, M
    ANNALS OF INTERNAL MEDICINE, 2003, 138 (04) : 299 - 306
  • [43] Osteopontin Levels in Patients with Hepatitis C Virus-related Hepatocellular Carcinoma
    Filik, Levent
    ARCHIVES OF MEDICAL RESEARCH, 2011, 42 (04) : 334 - 334
  • [44] Does hepatitis B virus therapy reduce the risk of hepatocellular carcinoma?
    Ridruejo, Ezequiel
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (03) : 439 - 451
  • [45] Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis
    Liu, Baoxian
    Wei, Mengchao
    Liu, Furong
    Chen, Shuling
    Peng, Zhenwei
    Li, Bin
    Zhou, Qian
    Wang, Haibo
    Peng, Sui
    Kuang, Ming
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (08): : 2685 - 2695
  • [46] The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis
    Chen, Xu-Xiao
    Cheng, Jian-Wen
    Huang, Ao
    Zhang, Xin
    Wang, Jian
    Fan, Jia
    Zhou, Jian
    Yang, Xin-Rong
    ONCOTARGETS AND THERAPY, 2017, 10 : 5363 - 5375
  • [47] Clinicopathological and Prognostic Value of Programmed Cell Death 1 Expression in Hepatitis B Virus-related Hepatocellular Carcinoma: A Meta-analysis
    Zhou, Zi-Yu
    Liu, Shao-Ru
    Xu, Lei-Bo
    Liu, Chao
    Zhang, Rui
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (06) : 889 - 897
  • [48] The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma
    Chiba, T
    Matsuzaki, Y
    Abei, M
    Shoda, J
    Tanaka, N
    Osuga, T
    Aikawa, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (06): : 1195 - 1203
  • [49] H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection
    Shen, Yu-Chuan
    Hsu, Hui-Ching
    Lin, Tzu-Min
    Chang, Yu-Sheng
    Hu, Li-Fang
    Chen, Lung-Fang
    Lin, Sheng-Hong
    Kuo, Pei-, I
    Chen, Wei-Sheng
    Lin, Yi-Chun
    Chen, Jin-Hua
    Liang, Yu-Chih
    Chang, Chi-Ching
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (11) : 1206 - +
  • [50] Clinical significance of antibody against hepatitis B virus core antigen in patients with hepatitis C virus-related hepatocellular carcinoma
    Yano, Y
    Yamashita, F
    Sumie, S
    Kuwaki, K
    Yamamoto, H
    Toyoda, N
    Ando, E
    Tanaka, M
    Sata, M
    LIVER INTERNATIONAL, 2003, 23 (04): : 227 - 231
12345